NCT03437460 is a NA clinical trial of Ibuprofen 600 mg in Pain, Chronic, sponsored by University of Pennsylvania.

Who is sponsoring NCT03437460?

NCT03437460 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT03437460?

Interventions in NCT03437460: Ibuprofen 600 mg, Prenatal vitamins.

What condition does NCT03437460 study?

NCT03437460 studies Pain, Chronic.

Is NCT03437460 still recruiting?

NCT03437460 is currently terminated. Last updated 3 August 2018.

Last reviewed 2018-08-03 · How we verify

NCT03437460

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Economic and Cognitive Effects of Pain Reduction

Terminated NA Last updated 3 August 2018

What this trial tests

NA trial testing Ibuprofen 600 mg in Pain, Chronic in 139 participants. Terminated before completion.

Timeline

10 May 2017

Primary endpoint
12 August 2017

12 August 2017

Quick facts

Lead sponsor	University of Pennsylvania
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	139
Start date	10 May 2017
Primary completion	12 August 2017
Estimated completion	12 August 2017
Sites	1 location across India

Drugs / interventions tested

Ibuprofen 600 mg — full drug profile →
Prenatal vitamins

Conditions studied

Pain, Chronic — all drugs for Pain, Chronic →

Sponsor

University of Pennsylvania

Who can join

Adults 25 to 65, female only, with Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Physical pain is a common but largely overlooked aspect of the lives of the poor. Not only does pain directly reduce life quality and happiness, it may also hamper cognitive function and, consequently, decision-making, productivity, and earnings. Workers with chronic pain may work fewer days, take longer breaks, and make less-considered choices regarding inputs; all outcomes that would reduce output and lead to greater impoverishment or impede the productivity and profitability of microenterprises and firms. The investigators will take the first steps in understanding the broader causal impact of physical pain on the cognitive and economic lives of the poor via a randomized controlled trial (RCT). 450 low-income women in Chennai, India, will be assigned to one of three treatment arms: 600 mg of over-the-counter pain medication, a placebo pill, or no medication. The research will quantify the causal impact of reduced pain on previously unstudied outcomes essential to escaping poverty including cognitive function, productivity, and earnings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ibuprofen 600 mg

Trials testing the same drug.

NCT06937853 — Effect of Genetic Polymorphisms on Response to Preoperative NSAIDs in Endodontic Postoperative Pain Management · NA · recruiting
NCT06247462 — Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat · Phase 1 · completed
NCT05548582 — Reduced Opioid Prescription After Laparoscopic Hysterectomy · NA · active not recruiting
NCT05355441 — Pain Multidisciplinar Intervention in Major Trauma Patients · completed
NCT04813991 — Pain Control Without Opioids · Phase 3 · withdrawn

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

NCT06800209 — Pain Reprocessing Therapy in Post-Operative Knee Pain · Phase 2 · recruiting
NCT06512727 — The PROACTIVE Study for Black Elders · NA · recruiting
NCT06837857 — Prescription Opioids, Brain Structure, and Cognition in Older Adults With Chronic Pain · Phase 2 · recruiting
NCT06541184 — Ziconotide for Non-cancer Pain by Intrathecal Administration · recruiting
NCT06592053 — Affecting Factors for Chronic Pain After Mastectomy · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03437460 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 3 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03437460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing